Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation

January 2026 | Volume 25 | Issue 1 | 48 | Copyright © January 2026


Published online December 29, 2025

Susan Taylor MDa, Pearl E. Grimes MDb

aDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA
bThe Grimes Center for Medical and Aesthetic Dermatology, Vitiligo and Pigmentation Institute of Southern California, Los Angeles, CA

Abstract
Background: Hyperpigmentation disorders are common skin concerns that negatively impact patient quality of life and self-perception. Hyperpigmentation results from the overproduction of melanin via a multi-step process with a rate-limiting step catalyzed by tyrosinase. Thiamidol, an effective human tyrosinase inhibitor, has recently been shown to reduce visible signs of hyperpigmentation and could provide additional benefits when combined with the standard of care treatment for hyperpigmentation: photoprotection, specifically sunscreens with sun protection factor (SPF).
Methods: A randomized study was performed with 95 subjects (n=47, Thiamidol regimen; n=48, standard SPF 30 lotion) aged 18–65 clinically presenting with facial hyperpigmentation (measured by colorimeter and individual typology angle [ITA°]) to assess the efficacy of the Thiamidol-containing regimen (Day Lotion with SPF 30 and Serum applied in the morning, Night Cream and Serum applied in the evening) compared with a standard SPF 30 lotion for 12 weeks, followed by a 6-week regression phase.
Results: Facial hyperpigmentation, measured by skin lightness, ITA° values, radiance, and shine, was significantly reduced relative to baseline for both groups as early as week 2, and significantly reduced for patients receiving the Thiamidol-containing regimen vs the standard SPF 30 lotion at weeks 8 and 12.
Discussion: This study demonstrates that while SPF alone can reduce the visible signs of hyperpigmentation, the addition of Thiamidol to a daily skin care regimen confers additional, durable benefits with regard to skin lightness, radiance, and shine.
Conclusion: These data support the integration of Thiamidol-containing formulations into existing skin regimens for individuals with facial hyperpigmentation.

 

INTRODUCTION

Pigmentary disorders (particularly melasma, postinflammatory hyperpigmentation, and solar lentigines) are among the most common skin disorders, impacting patient quality of life, perception by others, and even self-perception.1,2 Hyperpigmentation results from excess production of melanin induced by dysregulation of a multi-step synthesis process that converts tyrosine to L-DOPA via tyrosinase activity, eventually producing eumelanin and pheomelanin, which are deposited at the dermal and epidermal layers of skin.3

Excess melanin production may be initiated in response to skin injury, inflammation, certain medications, and sun exposure.4 Melanin confers skin pigmentation and affords some protection to the skin from ultraviolet radiation.5 Prolonged sun exposure stimulates melanogenesis, which generates superoxide and hydrogen peroxide, reactive oxygen species that can cause DNA damage and trigger inflammation, further upregulating melanogenesis.6,7 Additionally, in patients with inflammatory skin conditions, the levels of antioxidants, which neutralize reactive oxygen species, can be lower than in patients with healthy skin.8 As a result of the impact of prolonged sun exposure on excess melanin production, a fundamental aspect of hyperpigmentation management is the use of photoprotection (eg, photoprotective clothing, sunglasses, and topical application of sunscreen) to prevent worsening appearance of hyperpigmentation.9 Specifically, the use of broad-spectrum sunscreens with SPF is recommended as the standard of care for arresting hyperpigmentation, particularly sunscreens that provide visible light protection using iron oxide and/or neutralize reactive oxygen species using antioxidants.10-12 Common active treatments for hyperpigmentation (treatments that seek to reverse hyperpigmentation rather than just prevent further hyperpigmentation) include hydroquinone (often considered the most effective ingredient for hyperpigmentation), retinoids, kojic acid, chemical peels, laser therapy, and oral tranexamic acid, which have demonstrated some efficacy, but carry the risk of adverse effects and may not be as accessible as over-the-counter products due to price or the need for a doctor's visit or a prescription.9